Effect of inhibitors of aggregation on platelet ultrastructure in vitro.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D003042:Cocaine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008854:Microscopy, Electron; D009638:Norepinephrine / Q000494:pharmacology*; D009705:Nucleosides / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013710:Tendons; D013917:Thrombin / Q000494:pharmacology; D014020:Tissue Extracts; D014363:Tryptamines / Q000494:pharmacology
D000227:Adenine Nucleotides; D009705:Nucleosides; D014020:Tissue Extracts; D014363:Tryptamines; D012110:Reserpine; D004155:Diphenhydramine; D000255:Adenosine Triphosphate; D013917:Thrombin; D011398:Promethazine; D003042:Cocaine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine